Doctors test Direct-to-Spine drug combo for advanced brain cancer
NCT ID NCT06462222
Summary
This early-stage trial is testing a new two-part treatment for cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis). The study combines an immunotherapy drug given into the bloodstream with a chemotherapy drug injected directly into the spinal fluid. The main goals are to find a safe dose and see if this approach can help control the disease and extend survival for patients with advanced solid tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Affiliated Huizhou Hospital, Guangzhou Medical University
Huizhou, Guangdong, 516000, China
Conditions
Explore the condition pages connected to this study.